Non-pharmacological treatment in systemic sclerosis
Authors:
M. Špiritović 1,2; H. Štorkánová 1,3; S. Oreská 1,3; H. Šmucrová 1; B. Heřmánková 1,2; Romanowski Mw 4; D. Pavlů 2; M. Olejárová 1,3; M. Tomčík 1,3
Authors‘ workplace:
Revmatologický ústav
1; Katedra fyzioterapie, Fakulta tělesné výchovy a sportu, Univerzita Karlova, Praha
2; Revmatologická klinika, 1. lékařská fakulta, Univerzita Karlova, Praha
3; Department of Rheumatology and Rehabilitation, University of Medical Sciences, Poznań, Polsko
4
Published in:
Čes. Revmatol., 26, 2018, No. 1, p. 34-44.
Category:
Review Article
Overview
Systemic sclerosis (SSc) is a rare and very severe rheumatic disease for which no effective universal therapy exists. Organ manifestations significantly increase the mortality of these patients, nevertheless, the involvement of the skin and the musculoskeletal system also leads to higher morbidity, loss of function, and decreased quality of life. Literature data, as well as our experience, suggest that physical activity interventions are an inherent and integral part of the treatment of SSc patients. However, most existing studies dealing with non-pharmacological treatment of SSc patients are limited by their suboptimal methodological quality, insufficient number of patients, absence of a control group or lack of follow-up or a short duration of intervention. The purpose of this review article is to present important publications that deal with the safety and benefits of various non-pharmacological approaches that are at the forefront of clinical research interest in SSc.
Key words:
systemic sclerosis, fibrosis, rheumatic diseases, rehabilitation, physiotherapy, non-pharmacological treatment
Sources
1. Barsotti S, Stagnaro C, d'Ascanio A, Della Rossa A. One year in review 2016: systemic sclerosis. Clin Exp Rheumatol 2016; 34 Suppl 100(5): 3–13.
2. Gabrielli A, Avvedimento EV, Krieg T. Mechanisms of Disease: Scleroderma. New Engl J Med 2009; 360(19): 1989–2003.
3. Boin F, Rosen A. Autoimmunity in systemic sclerosis: current concepts. Current Rheumatol Reports 2007; 9(2): 165–72.
4. Ranque B, Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmunity Rev 2010; 9(5): A311–8.
5. Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32(4): 721–8.
6. Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017; 76 (8): 1327–39.
7. Capko J. Základy fyziatrické léčby. 1. vyd. Praha: Grada, 1998.
8. Sandqvist G, Akesson A, Eklund M. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil 2004; 26(16): 981–7.
9. Pils K, Graninger W, Sadil F. Paraffin hand bath for scleroderma. Phys Med Rehabil. 1991; 1(1): 19–21.
10. Askew LJ, Beckett VL, An KN, Chao EY. Objective evaluation of hand function in scleroderma patients to assess effectiveness of physical therapy. Br J Rheumatol 1983; 22(4): 224–32.
11. Mancuso T, Poole JL. The effect of paraffin and exercise on hand function in persons with scleroderma: a series of single case studies. J Hand Ther 2009; 22(1): 71–7; quiz 8.
12. Yuen HK, Marlow NM, Reed SG, Mahoney S, Summerlin LM, Leite R, et al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil 2012; 34(1): 84–9.
13. Maddali-Bongi S, Landi G, Galluccio F, Del Rosso A, Miniati I, Conforti ML, et al. The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial. Rheumatol Int 2011; 31(7): 895–901.
14. Poole J, Conte C, Brewer C, Good CC, Perella D, Rossie KM, et al. Oral hygiene in scleroderma: The effectiveness of a multi-disciplinary intervention program. Disabil Rehabil 2010; 32(5): 379–84.
15. Pizzo G, Scardina GA, Messina P. Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig 2003; 7(3): 175–8.
16. Bongi SM, Del Rosso A, Galluccio F, Sigismondi F, Miniati I, Conforti ML, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clinical Rheumatol 2009; 28(10): 1167–73.
17. Bongi SM, Del Rosso A, Galluccio F, Tai G, Sigismondi F, Passalacqua M, et al. Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol 2009; 27(3): S44–S50.
18. Alantar A, Cabane J, Hachulla E, Princ G, Ginisty D, Hassin M, et al. Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res 2011; 63(8): 1126–33.
19. Antonioli CM, Bua G, Frige A, Prandini K, Radici S, Scarsi M, et al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol 2009; 28(2): 159–65.
20. Kwakkenbos L, Bluyssen SJM, Vonk MC, van Helmond AF, van den Ende CHM, van den Hoogen FHJ, et al. Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. Clin Exp Rheumatol 2011; 29(2): S60–S5.
21. Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJJ, van der Giesen FJ, de Jong Z, Stolk J, et al. Randomized Comparison of a Multidisciplinary Team Care Program With Usual Care in Patients With Systemic Sclerosis. Arthritis Care Res 2011; 63(6): 909–17.
22. Rannou F, et al. Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2017 69(7):1050–1059.
23. Mugii N, Hasegawa M, Matsushita T, Kondo M, Orito H, Yanaba K, et al. The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. J Rheumatol 2006; 33(8): 1586–92.
24. Vannajak K, Boonprakob Y, Eungpinichpong W, Ungpansattawong S, Nanagara R. The short-term effect of gloving in combination with Traditional Thai Massage, heat, and stretching exercise to improve hand mobility in scleroderma patients. J Ayurveda Integr Med 2014; 5(1): 50–5.
25. Pinto AL, Oliveira NC, Gualano B, Christmann RB, Painelli VS, Artioli GG, et al. Efficacy and safety of concurrent training in systemic sclerosis. J Strenght Cond Res 2011; 25(5): 1423–8.
26. Alexanderson H, Bergegard J, Bjornadal L, Nordin A. Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study. BMC research notes. 2014; 7: 86.
27. Oliveira N, dos Santos Sabbag L, de Sa Pinto A, Borges C, Lima F. Aerobic exercise is safe and effective in systemic sclerosis. Int J Sport Med 2009; 30(10): 728–32.
28. Lima TR, Guimaraes FS, Carvalho MN, Sousa TL, Menezes SL, Lopes AJ. Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis. Braz J Phys Ther 2015; 19(2): 129–36.
29. Liddy C, Johnston S, Guilcher S, Irving H, Hogel M, Jaglal S. Impact of a chronic disease self-management program on healthcare utilization in eastern Ontario, Canada. Prev Med Rep 2015; 2: 586 – 90.
30. Samuelson UK, Ahlmén EM. Development and evaluation of a patient education program for persons with systemic sclerosis (scleroderma). Arthritis Care Res 2000; 13(3): 141–8.
31. Brown SJ, Somerset ME, McCabe CS, McHugh NJ. The impact of group education on participants' management of their disease in lupus and scleroderma. Musculoskeletal Care 2004; 2(4): 207–17.
32. Poole JL, Skipper B, Mendelson C. Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis. Clinical Rheumatol 2013; 32(9): 1393–8.
33. Poole JL, Mendelson C, Skipper B, Khanna D. Taking charge of systemic sclerosis: a pilot study to assess the effectiveness of an internet self-management program. Arthritis Care Res 2014; 66(5): 778–82.
34. Piga M, Tradori I, Pani D, Barabino G, Dessi A, Raffo L, et al. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology. J Rheumatol 2014; 41(7): 1324–33.
35. Seeger MW, Furst DE. Effects of splinting in the treatment of hand contractures in progressive systemic sclerosis. Am J Occup Ther 1987; 41(2): 118–21.
36. Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res 2011; 63(8): 1134 – 41.
37. Sallam H, McNearney TA, Doshi D, Chen JD. Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 2007; 52(5): 1329 – 37.
38. Kaada B. Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud‘s phenomenon and diabetic polyneuropathy). Eur Heart J 1982;3(4):303 – 14.
39. Tinazzi E, Amelio E, Marangoni E, Guerra C, Puccetti A, Codella OM, et al. Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int 2011; 31(5): 651–6.
40. Sporbeck B, Mathiske-Schmidt K, Jahr S, Huscher D, Becker M, Riemekasten G, et al. Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial. Rheumatol Int 2012; 32(5): 1469–73.
41. Uhlemann C, Abendroth K, Callies R, Gassel M. Multiple daily ultrasound treatment of patients with progressive systemic scleroderma. Dermatol Monatschr 1990; 176(5–6): 323.
42. Poděbradský J, Vařeka I. Fyzikální terapie I. Praha: Grada; 1998.
43. Milačić DM, Čobeljić KP, Isaković RU. Mouth opening scope in the patients with systemic sclerosis: Simultaneously application of a hyperbaric oxygenation and physical therapy. Materia Medica 2014; 30(3): 1186–9.
Labels
Dermatology & STDs Paediatric rheumatology RheumatologyArticle was published in
Czech Rheumatology
![Issue 1](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image/707bc16a0db73f9bba68b4d195079212.jpeg)
2018 Issue 1
Most read in this issue
- The significance of cerebrospinal fluid examination in neuropsychiatric systemic lupus erythematosus
- Non-pharmacological treatment in systemic sclerosis
- Ten Haar NM et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 2015; 74: 1636–1644.